Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.18B
Close$
$2.09
73.6% downside
Current Fair Value
73.6% downsideOvervalued by 73.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.18 Billion |
|---|---|
| Enterprise Value | $2.14 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.91 |
| Beta | 0.61 |
| Outstanding Shares | 147,996,000 |
Return
| Return on Equity | -37.82% |
|---|---|
| Return on Assets | -12.82% |
| Return on Invested Capital | -17.37% |
Valuation & Multiples
| P/E Ratio | -14.75 |
|---|---|
| PEG | 21.49 |
| Price to Sales | 7.9 |
| Price to Book Ratio | 3.95 |
| Enterprise Value to Revenue | 10.26 |
| Enterprise Value to EBIT | -21.82 |
| Enterprise Value to Net Income | -28 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$48.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$43.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3575▼ 57.95% |
|---|---|
| Total Calls | 380,100▲ 2.67% |
| Total Puts | 135,900▼ 60.82% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 95.50%▲ 12.57% |
|---|---|
| Total Invested | $881.88M▲ 156.56% |
| Investors Holding | 187▲ 22.00% |
ESG Score
No data
About Maravai LifeSciences Holdings Inc
3 employeesMaravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are ...